JOVANA FROM SERBIA WILL BE THE FIRST IN THE WORLD TO RECEIVE THE RUSSIAN CANCER VACCINE! A FAMOUS DOCTOR ANNOUNCED AND CONFIRMED: IT IS NOT CLINICAL TESTING, BUT TREATMENT!
Someone who is cured of melanoma with a vaccine, for example, can no longer get that form of cancer, explained Dr. Boljević.
TL;DR
- Jovana Aleksić, a patient from Serbia with metastatic melanoma, will be the first person in the world to receive a Russian cancer vaccine.
- The vaccine is personalized and will be produced at the 'Gamaleya' Institute.
- This is considered treatment, not a clinical trial.
- The vaccine can be used for all cancer types, but current focus is on melanoma and lung cancer.
- Artificial intelligence is used in the vaccine development process.
- The vaccine requires 10 doses, administered every two weeks, with effectiveness potentially visible after two to three doses.
- Patients from Russia and the Republic of Srpska are treated at the expense of the health fund, while patients from Serbia currently pay themselves unless agreements are made.
- The treatment is described as highly technological, expensive, but effective in nearly 95% of cases.
- Once cured by the vaccine, a patient cannot get the same form of cancer again.